Ran Qi
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
-
- Extracellular vesicles in disease
- RNA modifications and cancer
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 3
-
- Immunotherapy and Immune Responses 2
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 1
- Co-authors
- Nanbin Liu (3 shared papers)Yixuan Bai (3 shared papers)Baomin Shi (2 shared papers)Yufeng Wang (2 shared papers)Kun Li (2 shared papers)Hui Wang (1 shared paper)Rui Lin (1 shared paper)Zhongyan Liu (1 shared paper)
- Journals
- Translational Oncology (2 papers)Cell Transplantation (1 paper)European Journal of Pharmacology (1 paper)International Journal of Oncology (1 paper)Journal of Trace Elements in Medicine and Biology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ran Qi
15 papers receiving 454 citations
Ran Qi's Hit Papers
Peers
Comparison fields: 5 of 62
- Cancer Research 170
- Molecular Biology 302
- Immunology and Allergy 25
- Cell Biology 63
- Pulmonary and Respiratory Medicine 119
Countries citing papers authored by Ran Qi
This map shows the geographic impact of Ran Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Qi more than expected).
Fields of papers citing papers by Ran Qi
This network shows the impact of papers produced by Ran Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Qi. The network helps show where Ran Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs Hit paper breakdown → | 2023 | 190 |
| 2 | 2000 | 74 | |
| 3 | 2019 | 31 | |
| 4 | 2013 | 29 | |
| 5 | 2022 | 23 | |
| 6 | 2022 | 21 | |
| 7 | 2021 | 20 | |
| 8 | 2015 | 18 | |
| 9 | 2013 | 16 | |
| 10 | 2017 | 10 | |
| 11 | 2018 | 8 | |
| 12 | 2015 | 7 | |
| 13 | 2021 | 7 | |
| 14 | 2023 | 2 | |
| 15 | 2018 | 1 | |
| 16 | 2022 | 0 | |
| 17 | 2023 | 0 |
About Ran Qi
Ran Qi is a scholar working on Molecular Biology, Immunology, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 17 papers that have together received 457 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (2 papers), Spinal Cord Injury Research (2 papers), Immunotherapy and Immune Responses (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper), MicroRNA in disease regulation (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Cancer Research (170 citations), Molecular Biology (302 citations), Immunology and Allergy (25 citations), Cell Biology (63 citations) and Pulmonary and Respiratory Medicine (119 citations). Ran Qi has collaborated with scholars based in China and United States. Frequent co-authors include Nanbin Liu, Yixuan Bai, Baomin Shi, Yufeng Wang, Kun Li, Hui Wang, Rui Lin, Zhongyan Liu, Xiuyan Wang and Xinbo Li. Their work appears in journals such as Translational Oncology, Cell Transplantation, European Journal of Pharmacology, International Journal of Oncology and Journal of Trace Elements in Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.